Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
Year: 2015
Type: article
Study design: Clinical Trial
Authors: Noah M. Hahn, Beatrice S. Knudsen, Siamak Daneshmand, Michael O. Koch, Richard Bihrle, Richard S. Foster, Thomas A. Gardner, Liang Cheng, Ziyue Liu, Timothy Breen, Mark T. Fleming, Raymond Lance, Christopher L. Corless, Ajjai S. Alva, Steven S. Shen, Fangjin Huang, Arkadiusz Gertych, Gary E. Gallick, Jayati Mallick, Christopher Ryan, Matthew D. Galsky, Seth P. Lerner, Edwin M. Posadas, Guru Sonpavde
Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Cedars-Sinai Medical Center, University of Southern California, Oregon Health & Science University, USC Norris Comprehensive Cancer Center, Indiana University Health, Indiana University Indianapolis, Eastern Virginia Medical School, Virginia Oncology Associates, Urology of Virginia, Baylor College of Medicine, University of Michigan, U-M Rogel Cancer Center, Dan L Duncan Comprehensive Cancer Center, Houston Methodist, The University of Texas MD Anderson Cancer Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Alabama at Birmingham
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1862563098